Cite
Campese N, Palermo G, Del Gamba C, et al. Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases. Expert Rev Proteomics. 2021;18(1):27-48doi: 10.1080/14789450.2021.1886929.
Campese, N., Palermo, G., Del Gamba, C., Beatino, M. F., Galgani, A., Belli, E., Del Prete, E., Della Vecchia, A., Vergallo, A., Siciliano, G., Ceravolo, R., Hampel, H., & Baldacci, F. (2021). Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases. Expert review of proteomics, 18(1), 27-48. https://doi.org/10.1080/14789450.2021.1886929
Campese, Nicole, et al. "Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases." Expert review of proteomics vol. 18,1 (2021): 27-48. doi: https://doi.org/10.1080/14789450.2021.1886929
Campese N, Palermo G, Del Gamba C, Beatino MF, Galgani A, Belli E, Del Prete E, Della Vecchia A, Vergallo A, Siciliano G, Ceravolo R, Hampel H, Baldacci F. Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases. Expert Rev Proteomics. 2021 Jan;18(1):27-48. doi: 10.1080/14789450.2021.1886929. Epub 2021 Mar 07. PMID: 33545008.
Copy
Download .nbib